in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Ashland to Increase Polyvinylpyrrolidone Capacity
January 10, 2012 | Deepti Ramesh
Ashland says it will expand production capacity for Polyplasdone and Polyclar crosslinked polyvinylpyrrolidone (PVP) at its manufacturing facility at Texas City, in response to strong demand. The capacity expansion through the addition of a new PVP production unit at the site is expected to be completed by late 2013. Polyplasdone PVP is a synthetic polymer used globally as a tablet disintegrant and drug dissolution aid in a wide variety of over-the-counter and prescription drug products. Polyclar PVP is used by beer and wine producers as a filter aid during...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee